Italia markets open in 21 minutes
Dow Jones
39.308,00 -23,90 (-0,06%) Nasdaq
18.188,30 +159,54 (+0,88%) Nikkei 225
40.912,37 -1,28 (-0,00%) EUR/USD
1,0828 +0,0014 (+0,13%) Bitcoin EUR
49.820,18 -4.699,95 (-8,62%) CMC Crypto 200
1.129,00 -79,69 (-6,59%)
TEVA Jan 2026 30.000 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 09:49AM EDT. Mercato aperto.
| Chiusura precedente | 13,60 |
| Aperto | N/D |
| Denaro | 12,10 |
| Domanda | 13,30 |
| Prezzo d'esercizio | 30,00 |
| Scadenza | 2026-01-16 |
| Min-Max giorno | 13,60 - 13,60 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | N/D |
GlobeNewswireTeva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.
© 2024 Yahoo. Tutti i diritti riservati.